Geron Selvein Hosts '2025 PDRN Symposium'... "Sharing Paradigm in Dental Industry"

Pharmaceutical company Jeronselvain announced on the 16th that it will hold the '2025 PDRN Symposium' to welcome the new year.

Jeronselvain will hold the '2025 PDRN Symposium' on February 8, 2025, at the Grand Ballroom of Baekyangnuri, Yonsei University, Seoul.

The symposium will feature speakers including Professor Koo Ki-tae from Seoul National University Dental Hospital, Professor Kwon Yong-dae from Kyung Hee University Dental Hospital, Director Kim Sung-eon of Sejong Dental Clinic, Director Kim Yong-jin of Yesmir Dental Clinic, and Director Yoon Jong-il of Yeon Dental Clinic.

Each speaker will provide in-depth presentations on △Introduction to the basic mechanism of PDRN △Management of complications using PDRN △Overcoming difficult cases using PDRN △Immunological approaches using PDRN in periodontal disease treatment △Clinical cases of PDRN applicable in private clinics △Accurate understanding and clinical application of PDRN.

Kim Deok-gyu, CEO of Jeronselvain, said, “We are pleased to host a session where renowned domestic speakers can discuss various clinical cases and safety,” adding, “We will do our best to prepare so that participants can gain diverse information through the 2025 PDRN Symposium.”

Yoon Jong-il, director of Yeon Dental Clinic, emphasized, “The immunomodulatory and regenerative effects of PDRN have recently stood out significantly in dental fields such as periodontal disease and peri-implantitis,” and added, “Unlike conventional analgesics, anti-inflammatory drugs, or steroid agents, PDRN has tissue regeneration effects, and its excellence and safety have been proven through clinical applications in various fields, so it is expected to create remarkable innovations in the dental field.”

This content was produced with the assistance of AI translation services.